Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 13

1.

Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction.

Antoniou AC, Beesley J, McGuffog L, Sinilnikova OM, Healey S, Neuhausen SL, Ding YC, Rebbeck TR, Weitzel JN, Lynch HT, Isaacs C, Ganz PA, Tomlinson G, Olopade OI, Couch FJ, Wang X, Lindor NM, Pankratz VS, Radice P, Manoukian S, Peissel B, Zaffaroni D, Barile M, Viel A, Allavena A, Dall'Olio V, Peterlongo P, Szabo CI, Zikan M, Claes K, Poppe B, Foretova L, Mai PL, Greene MH, Rennert G, Lejbkowicz F, Glendon G, Ozcelik H, Andrulis IL; Ontario Cancer Genetics Network, Thomassen M, Gerdes AM, Sunde L, Cruger D, Birk Jensen U, Caligo M, Friedman E, Kaufman B, Laitman Y, Milgrom R, Dubrovsky M, Cohen S, Borg A, Jernström H, Lindblom A, Rantala J, Stenmark-Askmalm M, Melin B; SWE-BRCA, Nathanson K, Domchek S, Jakubowska A, Lubinski J, Huzarski T, Osorio A, Lasa A, Durán M, Tejada MI, Godino J, Benitez J, Hamann U, Kriege M, Hoogerbrugge N, van der Luijt RB, van Asperen CJ, Devilee P, Meijers-Heijboer EJ, Blok MJ, Aalfs CM, Hogervorst F, Rookus M; HEBON, Cook M, Oliver C, Frost D, Conroy D, Evans DG, Lalloo F, Pichert G, Davidson R, Cole T, Cook J, Paterson J, Hodgson S, Morrison PJ, Porteous ME, Walker L, Kennedy MJ, Dorkins H, Peock S; EMBRACE, Godwin AK, Stoppa-Lyonnet D, de Pauw A, Mazoyer S, Bonadona V, Lasset C, Dreyfus H, Leroux D, Hardouin A, Berthet P, Faivre L; GEMO, Loustalot C, Noguchi T, Sobol H, Rouleau E, Nogues C, Frénay M, Vénat-Bouvet L; GEMO, Hopper JL, Daly MB, Terry MB, John EM, Buys SS, Yassin Y, Miron A, Goldgar D; Breast Cancer Family Registry, Singer CF, Dressler AC, Gschwantler-Kaulich D, Pfeiler G, Hansen TV, Jønson L, Agnarsson BA, Kirchhoff T, Offit K, Devlin V, Dutra-Clarke A, Piedmonte M, Rodriguez GC, Wakeley K, Boggess JF, Basil J, Schwartz PE, Blank SV, Toland AE, Montagna M, Casella C, Imyanitov E, Tihomirova L, Blanco I, Lazaro C, Ramus SJ, Sucheston L, Karlan BY, Gross J, Schmutzler R, Wappenschmidt B, Engel C, Meindl A, Lochmann M, Arnold N, Heidemann S, Varon-Mateeva R, Niederacher D, Sutter C, Deissler H, Gadzicki D, Preisler-Adams S, Kast K, Schönbuchner I, Caldes T, de la Hoya M, Aittomäki K, Nevanlinna H, Simard J, Spurdle AB, Holland H, Chen X; kConFab, Platte R, Chenevix-Trench G, Easton DF; CIMBA.

Cancer Res. 2010 Dec 1;70(23):9742-54. doi: 10.1158/0008-5472.CAN-10-1907. Epub 2010 Nov 30.

2.

Modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: systematic review and meta-analysis.

Friebel TM, Domchek SM, Rebbeck TR.

J Natl Cancer Inst. 2014 Jun;106(6):dju091. doi: 10.1093/jnci/dju091. Review. Erratum in: J Natl Cancer Inst. 2014 Aug;106(8):dju235 doi:10.1093/jnci/dju235.

3.

Modifiers of breast and ovarian cancer risks for BRCA1 and BRCA2 mutation carriers.

Milne RL, Antoniou AC.

Endocr Relat Cancer. 2016 Oct;23(10):T69-84. doi: 10.1530/ERC-16-0277. Epub 2016 Aug 15. Review.

4.

Breast cancer susceptibility: current knowledge and implications for genetic counselling.

Ripperger T, Gadzicki D, Meindl A, Schlegelberger B.

Eur J Hum Genet. 2009 Jun;17(6):722-31. doi: 10.1038/ejhg.2008.212. Epub 2008 Dec 17. Review.

5.

Etiology of familial breast cancer with undetected BRCA1 and BRCA2 mutations: clinical implications.

Yiannakopoulou E.

Cell Oncol (Dordr). 2014 Feb;37(1):1-8. doi: 10.1007/s13402-013-0158-0. Epub 2013 Dec 4. Review.

PMID:
24306927
6.

Inherited mutations in breast cancer genes--risk and response.

Shuen AY, Foulkes WD.

J Mammary Gland Biol Neoplasia. 2011 Apr;16(1):3-15. doi: 10.1007/s10911-011-9213-5. Epub 2011 Apr 5. Review.

PMID:
21461995
7.

Common genetic variants and cancer risk in Mendelian cancer syndromes.

Antoniou AC, Chenevix-Trench G.

Curr Opin Genet Dev. 2010 Jun;20(3):299-307. doi: 10.1016/j.gde.2010.03.010. Review.

PMID:
20399636
8.

The contribution of breast cancer pathology to statistical models to predict mutation risk in BRCA carriers.

Vargas AC, Da Silva L, Lakhani SR.

Fam Cancer. 2010 Dec;9(4):545-53. doi: 10.1007/s10689-010-9362-5. Review.

PMID:
20577821
9.

Conservative management of breast cancer in BRCA1/2 mutation carriers.

Alpert TE, Haffty BG.

Clin Breast Cancer. 2004 Apr;5(1):37-42. Review.

PMID:
15140283
10.

Genetic susceptibility to breast cancer.

Bradbury AR, Olopade OI.

Rev Endocr Metab Disord. 2007 Sep;8(3):255-67. Epub 2007 May 17. Review.

PMID:
17508290
11.

Use of association studies to define genetic modifiers of breast cancer risk in BRCA1 and BRCA2 mutation carriers.

Hughes DJ.

Fam Cancer. 2008;7(3):233-44. doi: 10.1007/s10689-008-9181-0. Epub 2008 Feb 19. Review.

PMID:
18283561
12.

Clinical implications of low-penetrance breast cancer susceptibility alleles.

Freisinger F, Domchek SM.

Curr Oncol Rep. 2009 Jan;11(1):8-14. Review.

PMID:
19080736
13.

Effect of BRCA2 mutation on familial breast cancer survival: A systematic review and meta-analysis.

Shao J, Yang J, Wang JN, Qiao L, Fan W, Gao QL, Feng YJ.

J Huazhong Univ Sci Technolog Med Sci. 2015 Oct;35(5):629-34. doi: 10.1007/s11596-015-1481-7. Epub 2015 Oct 22. Review.

PMID:
26489613

Supplemental Content

Support Center